SIK3 Antikörper (C-Term)
Kurzübersicht für SIK3 Antikörper (C-Term) (ABIN1450082)
Target
Reaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- C-Term
-
Kreuzreaktivität (Details)
- Species reactivity (tested):Human, Mouse, Rat.
-
Aufreinigung
- Affinity chromatography purified via peptide column
-
Immunogen
- 18 amino acid synthetic peptide near the carboxy terminus of human SIK3
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Konzentration
- 1.0 mg/mL
-
Buffer
- PBS containing 0.02 % Sodium Azide as preservative
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handhabung
- Avoid repeated freezing and thawing.
-
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Store undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.
-
-
- SIK3 (SIK Family Kinase 3 (SIK3))
-
Andere Bezeichnung
- QSK
-
Hintergrund
- Salt-inducible kinase family (SIKs) proteins are thought to have a role in steroidogenesis, adipogenesis or regulation of tumor malignancy. Three members (SIK1, SIK2 and SIK3) in the SIK family have been identified thus far. Their kinase domain sequences are closely homologous to those of AMP-activated protein kinase (AMPK). SIK3 can be phosphorylated by a tumor-suppressor kinase LKB1. It is highly and preferentially expressed in ovarian tumors but not in adenomyosis and leiomyoma and may be a potential diagnostic marker for ovarian cancers.Synonyms: EC=2.7.11.1, KIAA0999, QSK, SIK-3, SIK3, Salt-inducible kinase 3, Serine/threonine-protein kinase QSK
-
Gen-ID
- 23387
-
NCBI Accession
- NP_079440
Target
-